Research and resources for perinatal professionals.
May 11, 2022 | by: Tanya Cawthorne, LCCE, FACCE
Tanya Cawthorne reviews a recently released book; “In Your Own Time - How Western Medicine Contrils the Start of Labour and Why this Needs to Stop” by Sara Wickham, MD examining labour inductions from an interesting perspective.
July 07, 2021 | by: Sharon Muza, BS, LCCE, FACCE, CD/BDT(DONA), CLE
The American College of Obstetricians and Gynecologists, in collaboration with the Society for Maternal Fetal Medicine, recently updated their recommendations on the timing of medically indicated late-preterm and early-term deliveries. The recommendations are based on placental, fetal and maternal complications. Late-preterm or early term refers to a delivery before 39 weeks and 0 days gestation.
May 26, 2020 | by: Mindy Cockeram, LCCE
It’s not easy to deal with the stress of pregnancy, labor and the postnatal period during the best of times but for most, Covid-19 has severely compounded the struggle. The cancellation of many in-person prenatal visits and childbirth and breast/chestfeeding classes and the lack of firm knowledge of how COVID-19 could affect parents and babies have stressed many people to the breaking point.
January 23, 2020 | by: Henci Goer
What are we to make of a new Swedish trial in which women were allocated by chance to either routine induction at 41 weeks or expectant management until 42 weeks (Wennerholm 2019)? The trial was stopped midway through because it had already shown a statistically significant increase, meaning unlikely to be due to chance, in perinatal mortality in the expectant management arm of the trial, and routine induction hadn’t increased the cesarean rate. You may be thinking, “It has long been established that 41-week induction is the better strategy for just these reasons. The Swedish trial just adds to the pile of studies finding in its favor.”
December 21, 2018 | by: Tanya Strusberg, LCCE, FACCE
Dr. Rachel Reed is a Senior Lecturer in Midwifery at the University of the Sunshine Coast, Australia. She is the author of the internationally-respected blog, Midwife Thinking. Dr. Reed has recently published a new book entitled, Why Induction Matters. Tanya Strusberg reviews it here.
August 16, 2018 | by: Sharon Muza, BS, LCCE, FACCE, CD/BDT(DONA), CLE
Neel Shah, MD, MMP shares his thoughts on the ARRIVE Trial. Dr. Shah is recognized as an innovative leader in maternal-infant health and a well-respected expert on effective methods for reducing the cesarean rate in the U.S.
August 14, 2018 | by: Henci Goer, BA
Henci Goer examines the just-released ARRIVE Trial to determine if there is new information compared to the study abstract that raises more questions or answers the old ones? What should birth professionals understand and share with consumers about the evidence to induce at 39 weeks?
February 13, 2018 | by: Henci Goer, BA
Author and evidence-based maternity care expert Henci Goer, a frequent Science & Sensibility contributor, examines the abstract of the ARRIVE Trial (the only published material from the study available at this time) and shares with S&S readers her careful examination of the study's conclusions.
July 13, 2015 | by: Henci Goer, BA
Today on Science & Sensibility, contributor Henci Goer takes a look at a systematic review released in spring that examined the impact of elective inductions on the cesarean rate. Sound analysis or a house of cards? Looking closer at the studies reviewed provides insight into how the
April 14, 2015 | by: Sharon Muza, BS, LCCE, FACCE, CD/BDT(DONA), CLE
Today on Evidence Based Birth, occasional contributor Rebecca Dekker, Phd, RN, APRN, provides a comprehensive research review Induction for Going Past your Due Date: What does the Evidence Say? I had an opportunity to preview the article and ask Rebecca some questions about her most recent proje
Subscribe by Email